These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8093712)

  • 1. Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides.
    Goubau P; Desmyter J; Swanson P; Reynders M; Shih J; Surmont I; Kazadi K; Lee H
    J Med Virol; 1993 Jan; 39(1):28-32. PubMed ID: 8093712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
    Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
    J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
    Abrams A; Akahata Y; Jacobson S
    Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
    Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
    J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
    Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
    J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens.
    Gallo D; Diggs JL; Hanson CV
    J Clin Microbiol; 1994 Sep; 32(9):2046-9. PubMed ID: 7814523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
    Lal RB; Brodine SK; Coligan JE; Roberts CR
    J Med Virol; 1991 Dec; 35(4):232-6. PubMed ID: 1687064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of human T cell lymphotropic virus infection and associated factors of risk in blood donors of Rio Branco city, AC, Brazil (1998-2001)].
    Colin DD; Alcântara Júnior LC; Santos FL; Uchôa R; Tavares-Neto J
    Rev Soc Bras Med Trop; 2003; 36(6):677-83. PubMed ID: 15049106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
    Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
    Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide.
    Lillehoj EP; Alexander SS; Dubrule CJ; Wiktor S; Adams R; Tai CC; Manns A; Blattner WA
    J Clin Microbiol; 1990 Dec; 28(12):2653-8. PubMed ID: 2279997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified western blot with recombinant antigens for serological differentiation between HTLV-I and HTLV-II.
    Chironna M; Quarto M; Germinario C; Fontana A
    New Microbiol; 1994 Jul; 17(3):177-85. PubMed ID: 7968652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
    Lal RB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S170-8. PubMed ID: 8797720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.
    Kariya N; Hayashi K; Hoshino H; Tanaka Y; Koirala TR; Ohara N; Miyamoto K; Akagi T
    Arch Virol; 1996; 141(3-4):471-80. PubMed ID: 8645089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV infection in ELISA-negative blood donors.
    Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
    AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.